Obviously the smart investors have a different mindset and don't pay 180 for fear they cannot sell quickly enough once earning and stock price start declining more
Analyst Neil Mawston sees Samsung holding on while Apple is under pressure:
Samsung’s new Galaxy S7 flagship and popular J series models are helping to hold steady its smartphone leadership [...] Apple is facing iPhone fatigue and pressure is mounting for Apple to innovate a new wow design beyond its standard rectangle form factor.”
no wonder the stock is tanking
Not going out of business next quarter, but the writing is on the wall, same symptoms as Blackberry, Nokia, Microsoft, and Apple will either stagnate for ten years like MS to catch up with innovation or drop off like Nokia and Blackberry.
Yes, made a mistake and didn't sell when the going was good, and had to pay for it dearly. Thank goodness I only had a few hundred shares, but the losses we pretty sizable when I finally sold in the sixties. You life and learn from your mistakes, some are more expensive than others. There is no need to get mean or ugly.
I do have other bio tech holdings, all hurting, e.g. AMGN, BIIB. CELG, (did manage to sell ALX around 200, almost at top) and SGEN at 46.
preapistic -now what are your thoughts on how the biotech trade will continue? I'd like to hear some constructive thoughts instead of the typical bashing, understand there has been some history.
I did establish a small position at average of about 38. as expected the stock recovered somewhat from the bottom but is moving sideways now. Contemplating selling or hanging on for a few more weeks